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Edited by Ned ManteiAbstract In the present study, we have explored the impact of
deleting a single allele of PDK1 in T cell progenitors on a/b
and c/d T cell development. The data show that deleting a single
allele of PDK1 allows diﬀerentiation of a/b T cells but prevents
their proliferative expansion in the thymus. Accordingly, mice
with T cells that are haplo-insuﬃcient for PDK1 have reduced
numbers of thymocytes and a/b peripheral T cells. T cell progen-
itors also give rise to c/d T cells but in contrast to the loss of a/b
T cells in T-PDK1 null and haplo-insuﬃcient mice, there were
increased numbers of c/d T cells. The production of a/b T cells
is dependent on the proliferative expansion of thymocytes and
is determined by a balance between the frequency with which
cells enter the proliferative phase of the cell cycle and rates of
cell death. Herein, we show that PDK1 haplo-insuﬃcient thymo-
cytes have no defects in their ability to enter the cell cycle but
show increased apoptosis. PDK1 thus plays a determining role
in the development of a/b T lymphocytes but does not limit c/d
T cell development.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: PDK1; Gamma delta T lymphocytes;
Haplo-insuﬃciency1. Introduction
Phosphoinositide-dependent kinase l (PDK1) phosphory-
lates a key threonine within the catalytic domain of a number
of AGC kinases including diacylglycerol regulated kinases of
the protein kinase C (PKC) family and phosphatidyl inosi-
tol-3 kinase (PI3K)-controlled serine kinases such as Akt or
protein kinase B (PKB) and the 70-kilodalton ribosomal S6 ki-
nase 1 (S6K1) [1–4]. PDK1 phosphorylation of AGC kinases is
essential for their activation and, accordingly, deletion of
PDK1 by homologous recombination removes one of the
rate-limiting regulators of multiple serine kinases and causes
embryonic lethality [5]. To circumvent this prenatal deathAbbreviations: DAPI; 40,6-diamidino-2-phenylindole; DN, double
negative; DP, double positive; FSC, forward scatter; MHC, major
histocompatibility complex; NLC, normal littermate control; PDK-1,
3 0-phosphoinositide-dependent protein kinase 1; PI, propidium iodine;
SP, single positive
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doi:10.1016/j.febslet.2006.03.022and explore the role of PDK1 in diﬀerent tissues, mice express-
ing PDK1 alleles ﬂanked with the loxP Cre excision sequence
(PDK1ﬂDneo/ﬂDneo mice) have been generated [5]. Thus, the im-
pact of tissue-speciﬁc deletion of PDK1 has been investigated
in cardiac muscle, where severe defects in cardiac function
caused embryonic lethality [6], and in liver which led to glucose
intolerance [7]. The importance of PDK1 in T lymphocyte
biology has also been explored by analysing T cell develop-
ment by deleting PDK1 in T cell progenitors in the thymus
using Cre expression driven by the proximal p56Lck promoter
[8,9]. There are two main lineages of T cells that direct the
adaptive immune response: alpha/beta (a/b) T cells that recog-
nise foreign antigen in the context of major histo-compatibility
(MHC) molecules and non-MHC restricted gamma delta (c/d)
T cells (reviewed in [10,11]). Deletion of PDK1 in T cell pro-
genitors in the thymus results in a block in the diﬀerentiation
of T cells that express a/b TCR complexes [8]. The fate of
c/d T cells following deletion of PDK1 in T cell progenitors
has not been examined. Since the signalling mechanisms that
control the development of a/b and c/d are divergent [11], we
cannot assume that the deletion of PDK1 in T cell progenitors
will equally impact a/b and c/d T cells.
The signalling mechanisms that control a/b T cell develop-
ment in the thymus are recapitulated in mature T cells as they
respond to foreign antigen. Accordingly, the impact of PDK1
deletion on a/b T cell diﬀerentiation indicates that inhibitors of
this molecule might be useful immunosuppressive drugs. How-
ever, gene deletion studies are of limited use as predictors of
the in vivo consequences of pharmacological inhibitors be-
cause most inhibitors will reduce rather than totally abrogate
enzyme function. It is thus more relevant to probe the cellular
impact of reduced expression of PDK1 because this will more
faithfully model the in vivo impact of a pharmacological inhib-
itor of PDK1. In this context, mice expressing hypomorphic
PDK1 alleles have been studied [5,12]. These have 10% of nor-
mal levels of PDK1 and are viable, although they are born
with reduced Mendelian frequency. PDK1 hypomorphic mice
have multiple defects including drastically reduced body mass
due to cellular growth defects. They also have defects in thy-
mocyte development; a/b T cell diﬀerentiation proceeds in
PDK1 hypomorphic mice but there is impaired proliferative
expansion of pre-T cells, which causes a reduction in numbers
of thymocytes and a/b T cells [8].
In PDK1 hypomorphic mice all cells of the body have re-
duced expression of PDK1 and there are multiple tissue defects
[5], which makes it impossible to be sure that the a/b T cell de-
fects are T cell autonomous. An attempt to circumvent thisblished by Elsevier B.V. All rights reserved.
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iments with PDK1 hypomorphic bone marrow [8]. These
experiments showed that the a/b T cell defects in PDK1 hypo-
morphic mice could be transferred with PDK1 hypomorphic
bone marrow arguing that the eﬀect was autonomous to hae-
matopoietic cells. However, to explore whether there are spe-
ciﬁcally T cell autonomous eﬀects of reduced PDK1
expression it is necessary to look at T cell function in mice with
T cell-speciﬁc reduction in PDK1 expression. Accordingly, the
present study explores the impact of T cell autonomous PDK1
haplo-insuﬃciency on thymocyte development. Selective dele-
tion of a single allele of PDK1 in T cell progenitors was
achieved by generating LckCre+PDK1+/ﬂDneo (T-PDK1+/)
mice. The data show that PDK1 haplo-insuﬃciency impairs
thymocyte development and the production of peripheral a/b
T lymphocytes. This is T cell autonomous and associated with
increased apoptosis of PDK1 haplo-insuﬃcient thymocytes.
Interestingly, numbers of c/d T cells are increased in mice with
a T cell speciﬁc deletion of either one or both PDK1 alleles.
These results show that a/b but not c/d T cell development is
sensitive to PDK1 loss.2. Methods
2.1. Transgenic mice
As described previously, T-PDK1/ mice were generated by cross-
ing mice whose PDK1 exons 3 and 4 were ﬂoxed on both alleles
(PDK1ﬂDneo/ﬂDneo) [5] with mice expressing Cre recombinase, driven
by the T cell-speciﬁc p56Lck promoter, resulting in ablated PDK1
expression in T cells [5,8]. In the current study, PDK1+/ﬂDneo mice were
crossed withmice expressing Cre recombinase under the control of the T
cell-speciﬁcproximal p56Lckpromoter to generateLckCre+PDK1+/ﬂDneo
(T-PDK1+/) mice, which have reduced PDK1 expression in T cells.
All mice used in these experiments were between 5 and 7 weeks of
age. Control mice used for analyses of T-PDK1+/ mice were age-
matched wild-type littermates.
Mice were bred and maintained in pathogen-free conditions at Well-
come Trust Biocentre, Dundee. Animal experimentation was approved
by Home Oﬃce Project License PPL60/3116.2.2. Flow cytometric analysis
Antibodies conjugated to ﬂuorescein isothiocyanate (FITC), phyco-
erythrin (PE), allophoycocyanin (APC) and biotin were obtained from
Pharmingen (San Diego, CA, USA). TriColour conjugated antibodies
were obtained from Caltag (Burlingame, CA, USA). Cells were stained
for surface expression of the following markers using the antibodies in
parentheses: CD4 (RM4-5), CD8 (53-6.7), CD25 (7D4), CD44 (IM7),
Thy1.2 (53-2.1), TCRb (H57-597), CD3e (145-2C11), B220 (RA3-6B2),
TCR c/d (GL3) and pan-NK (Dx5). Cells were stained with saturating
concentrations of antibody in reduced serum (2%) growth media and
data acquired on either a Calibur Fluorescence-Activated Cell Sorter
(FACS Calibur: Becton Dickinson, Franklin Lakes, NJ, USA) or a
LSR1 (Becton Dickinson). Events were collected and stored ungated
using CellQuest software. Data were analysed using either CellQuest
(Becton Dickinson) or FlowJo (Treestar, San Carlos, CA, USA) soft-
ware. Live cells were gated according to their forward-scatter (FSC)
and side-scatter (SSC) proﬁles.
CD4 and CD8 DN subsets were gated by lineage exclusion of all
CD4, CD8 double positive (DP) and single positive (SP) cells, as well
as cells of non-T cell lineages, using a panel of biotinylated antibodies
(to CD4, CD8, CD3, TCR c/d, B220 and Dx5) [13]. Mature SP thymo-
cytes were deﬁned as Thy-1+, TCRbhi and SP for CD4 or CD8.
Death of T lymphocytes was analysed by staining with annexin V
and 4 0,6-diamidino-2-phenylindole (DAPI). Thymocytes were gently
harvested and stained in media containing 2.5 mM CaCl2 with CD4,
CD8 and Thy-1 ﬂuorochrome-conjugated antibodies to identify thy-
mocyte subsets and annexin V–FITC and DAPI were included to iden-
tify dead and dying populations.2.3. Cell cycle analysis
The cellular DNA content of DN3 and DN4 thymocytes was ana-
lysed on live, saponin-permeabilised cells using 4,6-diamidino-2-pheny-
lindole dihydrochloride hydrate (DAPI) staining. Thymocytes (5 · 106)
were surface stained for CD25, Thy-1 and lineage markers (including
CD44). Cells were incubated for 15 min on ice in 800 ll DAPI staining
solution (5 lg/ml DAPI, 0.12% saponin in phosphate buﬀered saline
supplemented with 10 mM HEPES, pH 7.4, and 5% heat inactivated
foetal bovine serum) immediately prior to analysis. Events were col-
lected on either a FACS Calibur or an LSR1 with CellQuest software
and analysed with a doublet discrimination module, using either Cell-
Quest or FlowJo software.3. Results
To investigate the role of PDK1 in T lymphocytes, mice with
PDK1 null (T-PDK1/) and PDK1 deﬁcient (T-PDK1+/) T
cells were generated. T-PDK1/ mice have been described
previously [8]. These mice have a very small thymus with re-
duced numbers of thymocytes and almost no mature a/b
TCR positive T cells in the periphery. The data in Fig. 1 show
that deletion of a single PDK1 allele in pre-T cells also had a
severe impact on T cell development. T-PDK1+/ mice thus
had fewer thymocytes in total and produced markedly fewer
(55%) a/b TCR positive T lymphocytes in the periphery than
normal (Fig. 1A and 1C).
The thymus also gives rise to c/d T cells and we observed a
seven and threefold increase in c/d T cells in T-PDK1/ and
T-PDK1+/ thymi, respectively (Fig. 1B). To examine the
impact of PDK1 loss on the development of the c/d T cell
compartment we analysed the spleens of T-PDK1/ and
T-PDK1+/ mice for the presence of c/d T cell populations. In-
creased numbers of c/d T cells in the spleens of these mice was
observed (Fig. 1D). Numbers of splenic B lymphocytes were
not signiﬁcantly diﬀerent (Fig. 1E).
A reduction in numbers of a/b T cells can result from im-
paired thymocyte diﬀerentiation or impaired thymocyte prolif-
eration [14,15] and reviewed in [16,17]. T cell diﬀerentiation can
be staged by expression of the co-receptors for major histocom-
patibility molecules, CD4 and CD8 [18]. The earliest intra-thy-
mic progenitors are deﬁned by the absence of mature T lineage
markers (CD4/8 double negative (DN)) (reviewed in [19]). Fol-
lowing productive rearrangement of the TCRb locus, the
expression of a functional pre-TCR induces a proliferation
and diﬀerentiation program known as b-selection which can oc-
cur just prior to the onset of CD4 and CD8 expression in imma-
ture thymocytes [20]. These CD4+CD8+ double positive, DP
thymocytes rearrange their TCRa locus [21] and, following
the expression of a mature TCR a/b complex, these cells are se-
lected to either the CD4+ or the CD8+ single positive (SP) line-
age (reviewed in [22,23]). T-PDK1/ mice lack the normal
complement of CD4/8 DPs and comprise almost entirely of
DNs (Fig. 2A and [8]). In T-PDK1/+ mice DPs and SPs were
present but consideration of cell numbers showed that DN
numbers were moderately increased in T-PDK1+/ mice; nor-
mal littermate control (NLC) mice typically had approximately
4 · 106 to 7 · 106 DN cells, whereas T-PDK1+/ mice had
6 · 106 to 10 · 106 DN cells (Fig. 2B, left). In contrast, DP cell
numbers were reduced by at least a third in T-PDK1+/ mice
and absent in T-PDK1/mice (Fig. 2B, right). DP thymocytes
normally express a mature cell surface a/b TCR and are se-
lected to either CD4 or CD8 SP T cells (reviewed in [24]). T-
PDK1+/ mice had approximately 50% fewer CD4 and CD8
Fig. 1. Analysis of T lymphocytes in the thymus and periphery of PDK1 deﬁcient T-PDK1+/ mice. (A) Total thymocyte numbers from NLC
(n = 5), T-PDK1/ (n = 7) and T-PDK1+/ mice (n = 6). (B) Numbers of TCR c/d positive T cells in the thymus of NLC (n = 3), T-PDK1/ (n = 4)
and T-PDK1+/ (n = 3) mice. (C) Numbers of TCR a/b positive T cells in the spleen of NLC (n = 5), T-PDK1/ (n = 7) and T-PDK1+/ (n = 6)
mice. (D) Numbers of TCR c/d positive T cells in the spleen of NLC (n = 5), T-PDK1/ (n = 7) and T-PDK1+/ (n = 6) mice. (E) Numbers of B220+
B lymphocytes in the spleen of NLC (n = 5), T-PDK1/ (n = 6) and T-PDK1+/ (n = 4) mice. The data shown represent the means ± S.E.M. for
numbers of mice indicated.
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reduction in numbers of peripheral a/b T cells in the spleen of
these mice (Fig. 1C). Analysis of surface TCRb expression in
T-PDK1+/ mice revealed a lower than normal frequency of
cells expressing high surface TCRb Fig. 2D, consistent withFig. 2. Analysis of thymocytes subsets from T-PDK1+/ mice. (A) Flow cyto
PDK1/ and T-PDK1+/ mice. Two-dimensional dot plots of Thy-1-gated ce
CD4CD8 DN and CD4+CD8+ DP thymocytes from NLC (n = 4), T-P
represent the means ± S.E.M. for numbers of mice indicated. *P < 0.05. (C) N
and T-PDK1+/ (n = 4) mice. The data shown represent the means ± S.E.M
thymocytes from NLC, T-PDK1/, and T-PDK1+/ mice. Histogram overthe loss of DP and mature SP cells. As a/b T cells develop they
downregulate expression of CD24 and levels of CD24 on DPs
and SPs in T-PDK1+/ mice were normal (data not shown).
The downregulation of CD24 also accompanies c/d T cell mat-
uration [25]. There was an increase in the frequency of CD24metry of CD4 and CD8 subpopulations in thymocytes from NLC, T-
lls are representative of four independent experiments. (B) Numbers of
DK1+/ (n = 4), and T-PDK1/ (n = 3) mice. The numbers shown
umbers of SP CD4 (left) and SP CD8 (right) T cells from NLC (n = 4)
. for numbers of mice indicated. (D) Expression of TCRb on Thy-1+
lays are representative of four independent experiments.
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in normal mice), indicating an increase in the thymic frequency
of mature c/d T cells.
The phenotype of T-PDK1+/ mice in terms of a/b T cells is
consistent with a failure of proliferative expansion of thymo-
cytes. A large proliferative expansion of thymocytes occurs in
the DN thymocyte subset; it is estimated that each progenitor
entering the thymus and successfully proceeding through vari-
ous check points will undergo a several thousand fold expan-
sion prior to exiting the thymus (reviewed in [26]).
Accordingly, we examined the DN thymocytes in T-PDK1+/
mice in more detail. T cell progenitors within the DN popula-
tion can be developmentally staged on the basis of expression
of the CD44 and CD25 molecules: the ﬁrst progenitors are
CD44+/CD25 (DN1), followed sequentially by the CD44+/
CD25+ (DN2), CD44/CD25+ (DN3) and CD44/CD25
(DN4) population [27] and reviewed in [16,18]. Fig. 3A shows
the CD44/25 staining proﬁle of Thy-1 positive CD4/8 DN thy-
mocytes from NLC, T-PDK1/ and T-PDK1+/. T-PDK1+/
thymi contained both DN3 and DN4 subsets but displayed an
unusual pattern of CD25 expression on DN3 cells; CD25 levelsFig. 3. Analysis of CD4–CD8-DN subsets and total death in thymocytes of T
Thy-1+ DN cells from NLC, T-PDK1/, and T-PDK1+/ mice, addition
representative of four independent experiments. (B) Expression of CD25 in
mice; representative of four independent experiments. (C) Flow cytometry of
NLC and T-PDK1+/ mice. Numbers indicate percentage of cells in S + G2/M
(right) thymocytes from NLC, T-PDK1/, and T-PDK1+/ mice determ
representative of four independent experiments. (E) Dead and dying cells in N
ﬂow cytometry, based on DAPI and annexin V double staining. The data sh
Thymocytes from T-PDK1+/ mice were further analysed with CD4 and CD
dead (DAPI positive) thymocyte subsets.on DN3 cells were higher than normal (mean ﬂuorescence
intensity of 69 compared to 52 in normal mice) (Fig. 3B). There
is a similar shift to high CD25 expression in the DN3 cells of
T-PDK1/, already reported [8].
Intra-thymic T cell diﬀerentiation is a complex series of
events that are, in part, controlled by ‘checkpoints’ (reviewed
in [28,29]). One such checkpoint occurs in DN3 thymocytes
where successful TCRb locus rearrangements allow expression
of the pre-TCR complex, which then signals downregulation of
CD25 [30]. The high level of CD25 in T-PDK1+/ DN3s is thus
indicative of a problem in pre-TCR function. One role for the
pre-TCR is to act in synergism with cytokines to regulate cell
growth and cell cycle progression of T cell progenitors (re-
viewed in [31]). Deletion of PDK1 in T-PDK1/ mice is asso-
ciated with reduced cell cycle progression and reduced cell size
[8], so we explored the impact of PDK1 haplo-insuﬃciency on
cell cycle progression and on the size of DN thymocytes. The
data show that the percentage of T-PDK1+/ DNs in the pro-
liferative (S+G2/M) phases of the cell cycle of both DN3 and
DN4 cells were consistently higher than that seen in NLC DNs
(Fig. 3C). DN4 cells from NLC thymi were typically blastoid,-PDK1+/ mice. (A) Flow cytometry of CD44 and CD25 expression in
ally gated to exclude cells from the non-a/b TCR lineage (lineage);
lineageThy-1+ thymocytes from T-PDK1/, T-PDK1+/ and NLC
cellular DNA content of DN3 (left) and DN4 (right) thymocytes from
phases of the cell cycle. (D) Relative cell size of DN3 (left) and DN4
ined by ﬂow cytometry, based on forward light scatter. Data are
LC (n = 4) and T-PDK1+/ (n = 4) thymocytes were detected ex vivo by
own represent the means ± S.E.M. for numbers of mice indicated. (F)
8 staining, in the presence of DAPI, to detect live (DAPI negative) and
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were markedly smaller than NLC DN4s (Fig. 3D, right and
[8]). Cell size comparison by forward light scatter FACS anal-
ysis revealed that PDK1 haplo-insuﬃcient DN4s were slightly
larger than normal (Fig. 3D, right). DN3 cell size was no dif-
ferent to that of normal for both T-PDK1+/ and T-PDK1/
(Fig. 3D, left). The increased frequency of cycling cells in
PDK1 haplo-insuﬃcient DN4s could reﬂect a failure in the
rate at which these cells transit to the non-proliferating DP
stage of thymic development.
Rates of cell proliferation are determined by rates of cell cy-
cle entry and rates of cell death or apoptosis. To investigate the
reason for reduced thymic cellularity in T-PDK1+/ mice, thy-
mocytes of T-PDK1+/ and WT mice were examined for the
presence of dead and apoptotic cells using annexin V and
DAPI analysis. T-PDK1+/ thymocytes had a higher fre-
quency of apoptotic and dead cells than normal (Fig. 3E)
and more detailed analysis revealed that the reduced thymo-
cyte cellularity in T-PDK1+/ mice is associated with increased
cell death in the DN and DP thymic subsets (Fig. 3F).4. Discussion
Previous studies have shown that the loss of PDK1 has a se-
vere impact on T cell development and prevents the develop-
ment of mature a/b T cells by blocking the diﬀerentiation of
b selected T cell progenitors [8]. The present results now show
that PDK1 haplo-insuﬃciency also has a major impact on thy-
mocyte development and inhibits the development of a/b T
cells because of increased apoptosis of thymocytes as they de-
velop in the thymus. Strikingly, neither PDK1 loss nor haplo-
insuﬃciency in T cell progenitors prevents the development of
c/d T cells. Indeed, numbers of c/d T cells were increased in T-
PDK1+/ compared to WT mice. One puzzling result is that
loss of both alleles of PDK1 caused a larger increase in thymic
c/d cells than loss of a single allele, whereas the numbers of
splenic c/d T cells were similarly increased in T-PDK1 null
and haplo-insuﬃcient mice. The basis for this failure to achieve
a pro-rata increase in splenic versus thymic c/d T cells is not
clear but could reﬂect a niche limit for c/d numbers in the
spleen.
The diﬀerential requirements of c/d versus a/b T cell devel-
opment for PDK1 causes a thymus phenotype reminiscent in
part of that caused by loss of Notch1 and related genes in T
cell progenitors [32,33]. a/b versus c/d T cell development thus
has diﬀerential requirements for Notch signals (reviewed in
[11,34,35]). Notch signalling has been shown to regulate c/d
versus a/b T lineage commitment [32] and regulate cell metab-
olism in a/b T cell progenitors [36]. One question is whether the
increased frequency in c/d T cells in PDK1 null thymi reﬂects a
change in the frequency of c/d versus a/b lineage commitment.
In this respect, the frequency of b selected DN4s, as judged by
the frequency of DN4 thymocytes expressing high levels of
intracellular b chains, was similar in wild type or PDK1 null
DN4s (data not shown). These results argue that PDK1 loss
does not change the initial frequency of c/d versus a/b T line-
age commitment. A more likely explanation for the similarity
of the phenotype caused by loss of Notch signalling in pre T
cells to the PDK1 deletion phenotype is that Notch promotes
the survival of and development of a/b T cells by regulating the
activity of the PDK1 substrate AKT/PKB [36]. Accordingly,loss of PDK1 would prevent Notch regulation of cellular
metabolism which has been shown to be necessary for a/b cell
but not c/d T cell development (reviewed in [11,34,35]).
The relatively severe impact of PDK1 haplo-insuﬃciency for
a/b T cell development reveals that a/b T cell progenitors are
particularly sensitive to reduced PDK1 levels. Signalling path-
ways in immature T cells are frequently recapitulated in ma-
ture T cells. Hence, inhibitors of PDK1 would have a major
impact on the peripheral adaptive immune system. PDK1
could thus be an important target for immunomodulatory
drugs. The apparent insensitivity of c/d T cells to loss of
PDK1 could be functionally important as it could mean that
PDK1 inhibitors would not totally ablate adaptive immune re-
sponses and would leave the function of c/d T cells intact. This
may be an oversimpliﬁcation because the function of periphe-
ral c/d T cells is regulated by a/b T cells [37].
Recently, it has been proposed that PDK1 is a valuable drug
target for the treatment of cancer in conditions where there is
deregulation of the PI3K signalling pathways [38,39]. Of par-
ticular relevance to this is the ﬁnding that in a murine model
of haplo-insuﬃciency for loss of the PtdIns (3,4,5) P3 3-phos-
phatase, PTEN (phosphatase and tensin homolog deleted on
chromosome 10), reduction in PDK1 levels inhibits tumour
formation [12]. c/d T cells are thought to mediate anti-tumour
immunosurveillance [40–42], reviewed in [43,44] and hence the
eﬀects of reducing PDK1 levels on tumour formation may in-
clude indirect eﬀects caused by an increased frequency of c/d T
cells. This raises the intriguing possibility that PDK1 inhibitors
would not only have direct anti-tumour eﬀects but may also
promote anti-tumour immune responses. This is an optimistic
viewpoint bearing in mind that the extreme sensitivity of a/b T
cells to decreases in PDK1 expression indicates that pharmaco-
logical manipulation of PDK1 activity would have a major
impact on the adaptive immune system. This might be counter-
productive for tumour therapy.Competing interest statement
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